Recital 4, Commission Regulation (EC) No 507/2006 of 29 March 2006 on the conditional marketing aut…

In forcesince 29 Mar 2006

Where conditional marketing authorisations are granted, they should be restricted to situations where only the clinical part of the application dossier is less complete than normal. Incomplete pre-clinical or pharmaceutical data should be accepted only in the case of a product to be used in emergency situations, in response to public health threats.